Skin Aging: Endogenous and Extrinsic Drivers

Skin aging is influenced by both endogenous and exogenous factors. The endogenous factors primarily include the natural aging process, which is difficult to modify through human intervention. Endogenous aging is primarily influenced by the intrinsic biological aging process and is largely resistant to modification through external interventions. In contrast, extrinsic aging results from various environmental factors, including ionizing radiation, alcohol consumption, nutritional deficiencies, environmental pollutants, and most notably exposure to ultraviolet radiation, particularly UVB radiation. UV radiation can stimulate the expression of metalloproteases in the dermis, leading to collagen degradation and can also mediate inflammation through the production of reactive oxygen species, thereby accelerating skin aging.

PRP and Exosomes in Aesthetic Anti-Aging: Mechanisms and Rationale

Platelet Rich Plasma and exosomes both exhibit enhanced functionalities when used in aesthetic medicine. These include moisturizing barrier repair, antioxidant activity, photoprotection, anti-inflammatory effects and skin whitening properties. These diverse anti-aging mechanisms facilitate their integration into cosmetic treatments designed for comprehensive anti-aging applications. However, cutaneous aging is significantly accelerated by two interconnected pathologic factors: one, the inflammatory cascades that compromise cellular integrity, disrupt collagen and elastin homeostasis, and impair epidermal barrier function through the action of pro inflammatory mediators, and two, oxidative stress resulting from the accumulation of reactive oxygen species, which directly contributes to the structural aging of the skin. Therefore, mitigating inflammatory responses and enhancing antioxidant capacity are critical strategies for preventing and decelerating skin aging. Studies have shown that both exosomes and platelet rich plasma inhibit oxidative stress and reduce intracellular reactive oxygen species production by activating cellular pathways that combat this stress and promote production of collagen and elastin.

Which is a better vehicle for aesthetic anti-aging applications?

Platelet Rich Plasma (PRP) and Platelet Rich Fibrin (PRF): Definitions and Delivery

Platelet Rich Plasma is an autologous blood derived concentrate rich in cytokines, growth factors and bio active proteins. This resulting concentrate contains growth factors such as platelet derived growth factor, transforming growth factor-beta, vascular endothelial growth factor and epidermal growth factor and others implicated in tissue repair and collagen synthesis. PRP is a liquid applied via intradermal injection or by microneedling.

Platelet Rich Fibrin is also an autologous blood derived concentrate that is produced when the PRP is processed and allowed to form a clot. This clot is a fibrin matrix, rich in platelets, leukocytes and growth factors. The fibrin scaffold provides a more sustained release of bioactive molecules when compared to the PRP. This can then be injected for facial rejuvenation and wrinkle reduction.

Exosomes: Biologic Definition and Preparation

Exosomes are extracellular vesicles released by cells as part of intracellular communication. They are typically isolated from cell culture supernatants of mesenchymal stem cells or other engineered cell sources using ultracentrifugation, filtration, or other purification methods. Exosome preparations contain proteins, lipids, and nucleic acids capable of modulating cellular behavior.

Efficacy inFacial Rejuvenation

PRP/PRF

Multiple studies have shown that PRP/PRF improves skin thickness, elasticity, fine lines, texture, and some parameters of dyschromia, with most studies noting statistically significant improvement over baseline. Patient satisfaction has been reported as high in these studies and adverse events limited to mild transient events such as redness and swelling. A focused periorbital rejuvenation review found that PRF improved skin texture and creepiness whereas PRP showed a stronger efficacy for pigmentation improvement.

Exosomes

Human clinical evidence for exosome use in facial rejuvenation is still emerging. A notable split phase trial combining exosomes with radiofrequency microneedling showed both PRP and exosomes produced comparable improvements in wrinkling, texture, and pigmentation parameters. Comprehensive literature reviews highlight a promising early outcome for exosome applications in facial skin rejuvenation and hyperpigmentation, though the diversity of products and the lack of standard protocols limit broad conclusions.

Safety Considerations for PRP/PRF and Exosomes

PRP/PRF are derived from autologous blood, so risk of immunologic reactions is minimal. Reported adverse effects are generally mild and transient, such as injection site redness, swelling and or bruising. No serious adverse events are consistently documented in aesthetic applications and no long-term safety events have been reported. Therefore, safety appears favorable based on the published studies.

Exosome therapies, especially those derived from non-autologous sources, carry the theoretical risk of immune reactions or contamination and regulatory agencies such as the FDA consider many exosome preparations investigational outside of clinical trials. There is limited long term safety data, however mild transient effects such as redness or swelling have been reported in the literature with no serious adverse effects being reported and considered to be rare occurrence in clinical studies.

Satisfaction and Utilization in Aesthetic Practices

PRP/PRF: Multiple studies reported satisfaction scores that have been consistently positive reflecting perceived improvements in skin appearance even when objective measures were modest.

Exosomes : Clinical satisfaction metrics in controlled studies are emerging but generally positive. In split face trials, patients generally noted similar improvements on exosome treated and PRP treated sides.

Utilization: PRP/PRF are widely utilized in aesthetic clinics often combined with microneedling or lasers. Exosomes are newer and often marketed as the next generation of regenerative agents, sometimes combined with microneedling to facilitate deeper dermal delivery.

Which is the better choice in aesthetic applications?

Both PRP/PRF and exosomes offer promising regenerative approaches for facial regeneration and rejuvenation. PRP/ PRF is an autologous growth factor rich biologic with significant clinical experience and safety profiles. Exosomes are emerging as a cell free biologic that potentially provides a broader signaling modulation but there is limited long term data and appreciably higher cost. Since there is no comparison studies in the current literature between PRP and exosomes, the choice between these modalities should be guided by patient goals, budget, clinical context, and evidence expectations, as well as careful consideration of regulatory and safety standards.

At the present time, this author does not favor one modality versus the other, certainly both could be utilized for a gold standard treatment in aesthetic applications.

Studies and Evidence Base

Efficacy of Platelet Rich Plasma in Facial Rejuvenation: A Systematic Review

Enferm Clin 2025 Sep-Oct;35(5):502161 PMID 40118148

Aim: To evaluate the effects of PRP in facial rejuvenation.

Conclusion: Clinically, 4 studies indicated that PRP improves wrinkles and skin texture. Histologically, this substance induced a cascade of growth factors that increased dermal density, reducing wrinkles and improving skin luminosity and hydration. Therefore, Platelet Rich Plasma may be effective for facial rejuvenation based on histological results and patient references.

A Systematic Review of Platelet Rich Plasma Versus Platelet Rich Fibrin for Periorbital Rejuvenation

J Cosmet Dermatol 2025 Nov;24(11):e70524

Background: Platelet Rich Plasma and Platelet Rich Fibrin have become popular autologous options for facial rejuvenation due to their regenerative potential and favorable safety profiles. The periorbital region remains one of the most challenging treatment sites as conventional approaches, such as hyaluronic acid fillers, carry a risk of complications and may not provide a natural sustained result. This systematic review aims to compare injectable PRP and PRF in periorbital rejuvenation with emphasis on treatment protocols, efficacy, adverse effects and patient reported outcomes.

Conclusion: PRF shows promise in improving periorbital texture and fine lines, while PRP appears more effective for pigmentation. Current evidence does not support the superiority of one modality over the other.

Systematic Review of Platelet Rich Plasma and Platelet Rich Fibrin in Facial Rejuvenation

Ann Plast Surg 2025 Apr 1;94(4S Suppl 2):S376-S389 PMID 40167104

Background: Platelet Rich Plasma and Platelet Rich Fibrin are promising treatments for facial rejuvenation, leveraging growth factors to stimulate natural tissue repair and regeneration. Despite their growing popularity, their effectiveness remains controversial with studies yielding mixed results. This systematic review evaluates the current evidence on PRP/ PRF therapies and their effect on the following six key parameters of facial aging: wrinkles, texture, dyschromia, elasticity, skin thickness, and hydration.

Conclusions: This systematic review identified skin thickness and elasticity as the facial aging parameter with the strongest evidence of improvement following PRP/ PRF treatment. While skin hydration showed the weakest.

The Efficacy of MSC-Derived Exosome Based Therapies in Treating Scars, Aging and Hyperpigmentation: A Systematic Review of Human Clinical Outcomes

MDPI 2025 Dec 17;8(4):268 PMID 41441544

Background: Recent advancements in regenerative medicine have introduced mesenchymal stem cell derived exosomes as a novel therapeutic approach. Exosomes are extracellular vesicles containing proteins, lipids, and RNA, capable of modulating cellular behavior and promoting tissue regeneration. A systematic review of human studies is warranted to summarize outcomes, assess therapeutic value, and guide clinical applications. This systematic review synthesizes current evidence on mesenchymal stem cell derived exosomes for cutaneous scars, aging, and hyperpigmentation with a focus on functional and aesthetic outcomes.

Conclusions: Early human evidence suggests that exosomes may offer potential therapeutic benefits for scars, hyperpigmentation, and skin aging with favorable short term safety profiles. However, the current evidence remains preliminary due to small sample sizes, heterogeneous study designs, and limited follow-up durations.

Exosomes for Aesthetic Dermatology: A Comprehensive Literature Review and Update

J Cosmet Dermatol 2025 Jan;24(1):e16766 PMID 39764639

Background: Exosomes are nanoscale vesicles derived from various cell types and tissues that have many potential applications, generating great interest from researchers. One particularly intriguing application of exosomes is their use as a direct therapeutic for aesthetic indications. Several studies and case reports have explored the impact of exosomes for numerous cosmetic concerns but a consensus on the outcomes of these studies has not been established. In this review, we summarized the proposed mechanism of action, application, and efficacy of treatments with exosomes for alopecia and hair rejuvenation, facial rejuvenation, hyperpigmentation, and scars.

Conclusion: Exosomes may serve as a potentially beneficial therapeutic option for several aesthetic dermatologic indications, but further investigation is required to fully characterize the scope of their application.

Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges

J Drugs Dermatol 2025 Jan 1;24(1):12-18 PMID 39761139

Background: Exosomes are small extracellular vesicles that play a critical role in cellular communication transporting proteins, lipids and nucleic acids between cells. This literature review focuses on evaluating the potential benefits and limitations of exosomes in enhancing skin health and aesthetics through indications such as skin rejuvenation, hair restoration and pigmentation disorders.

Conclusion: While exosomes hold significant potential for non-invasive cosmetic dermatology, there are challenges that need to be addressed, including the standardization of exosome isolation and characterization, the establishment of safety profiles, and the conduct of extensive clinical trials.

Juventix Regenerative Medical Solutions for Aesthetic Professionals

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility, effectiveness and ease of use. They provide a reproducible platelet concentrate, devoid of red blood cells with a small number of leukocytes, that are needed for the regenerative process.

Juventix LED Platelet Activator for Growth Factor Release

Juventix Regenerative Medical provides an LED Activator to activate the platelets and begin the regenerative process. This activation is a critical step in the release of growth factors, cytokines and bio active proteins from the granules that are contained on the platelets and is accomplished by LED light. This negates the use of chemical additives such as calcium chloride, thrombin or collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation, while adhering to the minimal manipulation standards of the FDA.

Juventix Bio-Incubator for Injectable Platelet Rich Fibrin

Juventix Regenerative Medical offers the Bio-Incubator. This device transforms the Platelet Rich Plasma into an injectable Platelet Rich Fibrin. The Platelet Rich Fibrin is often called “the second generation of platelet products” and has different cytokines and growth factors than the original PRP. These cytokines and growth factors create an anti-inflammatory microenvironment and can be utilized when an anti-inflammatory treatment is desired.

Juventix Product Portfolio for Regenerative and Aesthetic Clinics

Juventix Regenerative Medical has a vast array of products, devices and services tailored for the medical and regenerative professional. Our premier line of products includes a patented Biotin PRP kit for hair restoration and a non-crossed linked hyaluronic acid kit for aesthetic filler applications. Through our collaboration with tissue product regenerative companies, such as New Life Medical, exosomes and other products are available.

Enhancing Clinical Outcomes and Patient Satisfaction

Juventix Regenerative Medical is poised to aid any medical or aesthetic professional in enhancing clinical outcomes while increasing patient satisfaction.

RESTORE, REVIVE, REGENERATE- JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,

Dr. Robert McGrath

The post PRP vs Exosomes for Skin Rejuvenation appeared first on Juventix.

Overview of Shoulder Pain and Rotator Cuff Injuries

Shoulder pain is the third foremost musculoskeletal condition and it’s occurrence increases over age with a lifetime incidence of about 70% and is highest in the 40 to 59 year old individuals linked to a substantial socioeconomic burden. Rotator cuff injuries are the most frequent cause of shoulder pain accounting for over 70% of such complaints.

Anatomy of the Shoulder Joint

The shoulder joint (glenohumeral join) is a synovial ball and socket joint between the humeral head and the shallow glenoid fossa of the scapula. Stability of the joint is a function of the glenoid labrum and the tendons of the rotator cuff that blend with the capsule.

Rotator Cuff Structure

The rotator cuff of the shoulder joint is comprised of 4 tendons that stabilize the glenohumeral joint.
A. Supraspinatus (initiates abduction)
B. Infraspinatus (external rotation)
C. Subscapularis (internal rotation)
D. Teres Minor (external rotation, humeral stabilization)
The tendons of the rotator cuff converge around the humeral head, forming a dynamic stabilization cuff.

Pathology of the Rotator Cuff

1. Tendinitis: acute inflammatory pain from tendon overload.
   B. Tendinosis: chronic degenerative changes with collagen disorganization and neovascularization with minimal classic inflammation.
   C. Partial Thickness Tears: articular, bursal or intratendinous fiber disruption Defined as incomplete tendon involvement.
   D. Full Thickness Tears: tendon discontinuity from articular to bursal surface with small to massive retraction and fatty infiltration. Tendon detaches entirely from the bony insertion.

Epidemiology

Approximately 2 million individuals seek medical attention annually for rotator cuff tears. The most frequently injured tendon is the supraspinatus tendon.

Age: Rotator tears are common and age related
A. 20–30% in middle age
B. 40% greater than 60 years of age
C. Up to 80% greater than 80 years old
Many of the above cases are asymptomatic at discovery and found only by complaints of decreased ROM

Surgical Intervention for Rotator Cuff Injuries

Contemporary US database estimate greater than 250,000 rotator repairs are done annually with a steady increase yearly in the US. Most performed arthroscopically vs open repairs.
Surgery is favored for acute traumatic tears in young patients or in large retracted tears with progressive weakness after 3 months of failed conservative treatment.

Operative Outcomes

Retear/nonhealing rates vary with age, tear size, tissue quality and other comorbidities. Meta analysis shows a retear rate of 12-37% average across all tear categories.

1. Risk of retear doubling from age 50 to 70
   B. Retear rate raises sharply for large massive tears

Other post operative complication of surgery
A. Postoperative stiffness and decrease ROM.
B. Persistent pain and or dysfunction
C. Fatty infiltration and calcification of operative site
D. Total healing rates decreased in diabetes, higher BMI, smokers and subscapularis involvement.

Conservative Management Approaches

Conservative management modalities to manage rotator cuff injuries include the use of pharmacological agents such as non-steroidal anti-inflammatory drugs, corticosteroids and opioids and non-pharmacological options such as physical therapy, activity modification, acupuncture, and electrical therapies. These traditional options have flaws and side effects and typically provide only short-term symptomatic relief instead of addressing the underlying pathologies associated with rotator cuff injuries.

Biologics and Device Based Therapies

Platelet Rich Plasma

1. Mechanism: Delivers growth factors (PDGF, TGF-Beta, and many others) to stimulate tenocyte proliferation and matrix remodeling.
2. Evidence:
3. Improved pain and function in short to mid term for tendinopathy/partial tears
4. Reduced structural failure rates when used as surgical augmentation, especially in large tears.
5. Benefits persist for 6-12 months
6. Excellent safety profile with the main side effect of soreness and injection site.

Extracorporeal Shock Wave Therapy (ESWT)

1. Mechanism: Induces mechanotransduction to promote angiogenesis and tissue remodeling: modulates pain.
2. Evidence:
3. Calcific tendinopathy: Strong support for pain relief and calcific deposit resorption
4. Non-Calcific tendinopathy: benefits of pain reduction and increased function.
5. Safety profile is excellent with transient discomfort and erythema at site of treatment as the most common reported complaints.

 Exosome Based Therapies

1. Mechanism: MSC derived exosomes deliver mRNA and other proteins promoting macrophage polarization, tenocyte proliferation and tissue synthesis.
2. Evidence:

Robust in vitro and animal data supporting the use of exosomes alone and in combination with PRP and ESWT.

Clinical Studies Supporting Regenerative Therapies

PRP Study Summary

Platelet Rich Plasma Therapy for Rotator Cuff Injuries: A Comprehensive Review of Current Evidence and Future Directions
Cureus 2024 Sept 23;16(9):e70042 PMID 39449946

Purpose: This review comprehensively evaluates the current evidence regarding PRP therapy for rotator cuff injuries. It examines clinical trial data comparing PRP therapy with conventional treatments such as physical therapy and surgical intervention. The review also explores the biological mechanisms of PRP including its role in promoting tendon repair and regeneration through growth factors and cytokines.

Conclusion: PRP therapy is promising for treating rotator cuff injuries, offering potential benefits and accelerated healing, reducing pain and improved functional outcomes. The evidence from clinical trials suggests that PRP therapy may be an effective adjunct or alternative to traditional treatments such as physical therapy and surgery particularly for individuals seeking to avoid more invasive procedures.

ESWT Study Summary

Effect of Extracorporeal Shockwave Therapy for Rotator Cuff Tendinopathy: A Systematic Review and Meta-Analysis
BMC Musculoskelet Disord 2024 May $;25(1):357 PMID 38704572

Purpose: Rotator cuff tendinopathy is a widespread musculoskeletal disorder and a primary cause of shoulder pain and limited function. The resulting pain and limited functionality have a detrimental effect on the overall quality of life. The purpose of this study was to perform a systematic review of the effects of extracorporeal shockwave therapy for rotator cuff tendinopathy.

Conclusion: Currently evidence suggests that compared with the control groups, extracorporeal shockwave therapy can provide better pain relief, functional recovery and maintenance of function in patients with rotator cuff tendinopathy.

Exosome Study Summary

Therapeutic Potential and Mechanisms of Mesenchymal Stem Cell Derived Exosomes as Bioactive Materials in Tendon Bone Healing
Nanobiotechnology 2023 Jan 16;21:14 PMID 36642728

Purpose: Exosomes are nanosized extracellular vesicles with a lipid bilayer and a membrane structure are naturally released by various cell types. They play an essential role in intercellular communication by transferring bio- active lipids, proteins and nucleic acids such as messenger RNA between cells to influence physiological and pathological process of recipient cells. Exosomes have been shown to facilitate tissue repair and regeneration. Herein, we discuss the prospective applications of mesenchymal stem cell derived exosomes in tissue bone insertion injuries.

Conclusion: In regenerative medicine, stem cell therapy is an effective strategy for tissue repair and regeneration. In recent years, an increasing number of studies have shown that the beneficial effects of stem cell therapy are mediated by exosomes secreted by the paracrine action of mesenchymal stem cells which provide a new potential cell free therapy for enhancing tendon bone healing. With further research, we have found that mesenchymal stem cell exosomes may regulate macrophage polarization, promote angiogenesis, enhance osteogenesis and suppress osteolysis. Furthermore, exosomes are rich in a variety of nucleic acids, multiple proteins and bio-active lipids which primarily function as intracellular communication carriers to deliver these molecules between cells to trigger a biological response. In recipient cells, recent studies have shown that exosomes can combine biomaterials to facilitate tendon bone healing. In summary, although these studies did not establish a precise healing mechanism, they identified the great potential of exosomes in the treatment of tissue bone injuries such as rotator cuff injuries.

Juventix Regenerative Medical Solutions

Juventix Regenerative Medical is a leader in the field of regenerative medicine. Juventix provides solutions and answers to the difficult to treat injuries and diseases of the rotator cuff. Our Platelet Rich Plasma kits are designed for safety, sterility and effectiveness. They reach concentrates of platelets that are consistent with the recommended standards for treatment given normal platelet values.

Platelet Activation and Fibrin Transformation Technologies

In the aged population or with patients that have other disease states, Juventix Regenerative Medical offers the LED Platelet Activator. With polychromatic light, the platelet concentrate is activated and growth factors and cytokines are released from the granules on the platelets. This achieves a higher concentrate of the bio-active molecules and provides enhanced outcomes in the treatment thus equaling the playing field in patients with lower platelet values.

Juventix Regenerative Medical has the Bio-Incubator to transform the Platelet Rich Plasma into Platelet Rich Fibrin. Platelet Rich Fibrin is termed the “second generation of platelet products” and had different cytokines and growth factors than the original PRP. These cytokines and growth factors provide an anti-inflammatory microenvironment and can be utilized for a longer treatment in inflammatory conditions.

Device-Based Therapies from Juventix

Juventix Regenerative Medical offers the PhysioPRO Extracorporeal Shockwave Device. This radial shockwave device can be utilized in the treatment of many musculoskeletal conditions and injuries. It is a simple, cost-effective treatment modality to decrease pain and increase angiogenesis while modulating neogenesis. As a class one device, it can be operated by ancillary personnel in the office. The PhysioPRO is extremely easy to use as treatment protocols are already programmed into the device as well as the number of recommended treatments needed to achieve the goals.

Clinical Use of Exosomes

Through collaboration with certified regenerative labs, Juventix Regenerative Medical can provide exosomes for clinical use. These tissue products are humanely harvested, processed under the strictest guidelines and never lyophilized. They are shipped on dry ice for use in the treatment protocols of many injuries and disease states.

RESTORE, REVIVE, REGENERATE- JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,

Dr. Robert McGrath

The post Rotator Cuff Pathology and Juventix Regenerative Medical Solutions appeared first on Juventix.

Glycolic Acid on the Scalp: Why Clinicians Should Pause Before Adopting the Trend

Glycolic acid has migrated from facial peels into hair-care marketing, where it is promoted as a “scalp exfoliant” that can supposedly stimulate hair growth. In practice, the data tells a different story…

Consumer-facing brands and blogs frequently highlight theoretical benefits, removal of sebum, desquamation of keratin, and flake control, but acknowledge that there is no robust clinical evidence that glycolic acid reverses androgenetic alopecia (AGA) or other common causes of hair loss.

Dermatology-oriented reviews emphasize that:

• Evidence for hair regrowth is limited to anecdote and speculative mechanisms rather than controlled trials.
• Over-use or high concentrations can cause barrier disruption, erythema, burning, and chemical irritation, particularly on already-inflamed scalps.
• Repeated irritation may weaken hair shafts at the ostia and exacerbate shedding, especially when acids are layered with other active agents or left on too long.

For patients already anxious about hair loss, adding an unpredictable irritant on top of AGA, telogen effluvium, or traction alopecia can be counter-productive. Clinically, glycolic acid may have a niche in managing scale or seborrheic dermatitis, but it is not a hair-restoration therapy.

Beyond Finasteride and Caustic Acids: Why Providers Are Moving Toward Regenerative Options

At the same time, regulatory and pharmacovigilance developments are forcing a re-evaluation of systemic hair-loss drugs. In May 2025, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) confirmed suicidal ideation as a side effect of finasteride 1 mg and 5 mg tablets, widely used for AGA, and implemented new risk-minimization measures.

While these drugs remain important tools, many primary-care, aesthetic, and regenerative medicine clinics are asking:

“Can we deliver meaningful hair regrowth without chronic systemic exposure or aggressive chemical peels?”

Current evidence suggests the answer is yes! Through autologous and biologic regenerative strategies such as Platelet-Rich Plasma (PRP), Biotin (B7), and advanced topicals that leverage the patient’s own growth factors, as well as potential allogeneic sources (exosome-augmented protocols).

PRP for Hair Loss: From “Experimental” to Evidence-Based Standard of Care

Multiple randomized controlled trials and meta-analyses now support the efficacy of platelet-rich plasma (PRP) in androgenetic alopecia:

• A recent meta-analysis of randomized trials found that PRP significantly increased hair density and hair count versus baseline or placebo, with a favorable safety profile.
• Head-to-head and adjunctive studies suggest PRP can match or outperform topical minoxidil in some cohorts and enhance outcomes when combined with standard pharmacotherapy.

PRP infusion at the follicular level activates key signaling pathways, VEGF, PDGF, IGF-1, to enhance dermal papilla function and transition resting follicles back into the active anagen phase.

Mechanistically PRP delivers supraphysiologic concentrations of platelet-derived growth factors (PDGF, VEGF, IGF-1, TGF-β and others) that:

• Prolong the anagen phase
• Enhance perifollicular microcirculation
• Modulate inflammation and stimulate dermal papilla cell proliferation

This regenerative profile directly addresses key elements of hair-follicle miniaturization, in contrast to glycolic acid, which primarily functions as a keratolytic surface agent.

Biotin (B7) + PRP: A Patented Innovation from Juventix

Biotin plays a recognized role in keratin infrastructure and has been associated with improved hair parameters in deficient patients. However, oral supplementation alone is limited by gastrointestinal degradation and variable adherence.

To address this, Juventix Regenerative Medical developed a one-step PRP harvesting kit that integrates liquid biotin directly within the PRP collection tube. The U.S. patent application “Kit Including Biotin for Harvesting Platelet-Rich Plasma” (US 2023/0038636 A1) describes a PRP tube containing:

• A gel separator to partition red blood cells and granulocytes
• An anticoagulant above the gel layer
• Liquid biotin in injectable form located below the gel separator, enabling simultaneous preparation of PRP and biotin in a closed, chemical-free system for hair-loss treatment.

In October 2025, the United States Patent and Trademark Office issued a Notice of Allowance for this non-provisional utility patent application (Application No. 17/877,268), confirming that the claims are allowed for issuance as a U.S. patent.

For clinicians, this means:

• A procedural-ready, patent-protected PRP + Biotin kit designed specifically for hair restoration
• Closed-system preparation that minimizes manipulation and contamination risk
• The ability to deliver growth factors and biotin directly to the follicular microenvironment in a single step

In a therapeutic landscape crowded with unregulated topicals and off-label acid treatments, a clearly defined, protected methodology offers both scientific and medico-legal advantages.

From In-Office to At-Home: Needle-Free Delivery with PRiVIVE™ Topical Serum

Clinics also need a way to extend in-office PRP outcomes into the home setting without asking patients to inject themselves or rely on harsh chemicals.

This is where PRiVIVE™ Topical Serum functions as a bridge between regenerative medicine and advanced cosmeceutical delivery:

• PRiVIVE™ uses a proprietary, clinically demonstrated self-contained delivery technology (ALM DT) that enhances dermal permeation and cellular utilization of active compounds without external devices. Its mechanism has been likened to a form of “chemical electroporation” that transiently increases transcellular and intercellular transport without damaging tissue.
• In an ex-vivo human skin model (Mattek), platelets carried within a platelet-rich fibrin matrix plus ALM DT crossed the stratum corneum by 4 hours, reached the basal cell layer by 24 hours, and produced a four-fold increase in fibrin at the basal membrane along with elevated IL-6, indicating biologic activity, without observable histologic damage.

Combined with PRP, this suggests a practical, clinically tested pathway to “inject PRP without needles” by applying a patient-specific PRP-enriched PRiVIVE serum onto intact scalp or skin immediately after in-office procedures.

PRiVIVE is also formulated with additional regenerative ingredients that support scalp and skin health:

• Centella asiatica extract (Gotu Kola) – promotes fibroblast proliferation, collagen synthesis, and tensile strength of healing skin
• Palmitoylethanolamide (PEA) – a lipid mediator that engages the cutaneous endocannabinoid system to modulate inflammation and barrier function
• Oligopeptide-1 (Epidermal Growth Factor, EGF) – supports keratinocyte proliferation and extracellular matrix synthesis
• Syn-Ake® (dipeptide diaminobutyroyl benzylamide diacetate) – a biomimetic peptide used to relax localized muscle contraction and improve vasodilation
• Helichrysum essential oil – provides antioxidant support and barrier protection

To date, no adverse effects have been reported across multiple PRiVIVE-based formulations, and in vitro testing on human skin tissue cultures has shown no irritation or structural tissue damage.

In practice, Juventix providers are using PRiVIVE as:

• A topical extension of Juventix Biotin PRP hair-restoration protocols (often combined with derma-rolling)
• A take-home maintenance serum to sustain growth-factor exposure between treatment sessions
• An adjunct following microneedling procedures of the scalp and skin

For hair restoration specifically, this creates a coherent continuum: in-office Juventix PRP + Biotin injections → immediate topical PRiVIVE application → ongoing home use of a PRP-customized serum, all while avoiding the mechanical trauma of needles at home and the risks of chronic acid-based exfoliation.

Adjunctive Technologies: LLLT and Exosome-Augmented Protocols

To further optimize outcomes, many practices layer Juventix PRP + Biotin and PRiVIVE with:

• Low-Level Laser Therapy (LLLT): Meta-analyses of randomized trials show LLLT significantly improves terminal hair counts in AGA and is well tolerated, particularly when used alongside other therapies.
• Exosome-enhanced strategies: Early clinical and preclinical work suggests exosomes derived from dermal papilla or mesenchymal stem cells can activate Wnt/β-catenin signaling, support anagen entry, and augment PRP responses in difficult hair-loss phenotypes. PRiVIVE is engineered specifically to accommodate PRP or exosomes in the same delivery platform, providing needle-free deployment of these autologous or allogenic biologics.

Key Clinical Takeaways for Providers Considering Alternatives to Glycolic Acid:

1. Glycolic acid is not a hair-restoration therapy. Evidence for true regrowth is weak, whereas the potential for irritation, barrier damage, and worsening telogen effluvium is very real, particularly in already-sensitized scalps. (Source: NovaMane)
2. PRP has evolved from “experimental” to evidence-based standard of care. Randomized trials and meta-analyses now consistently show improvements in hair density, with a safety profile that compares favorably to chronic pharmacotherapy.(Source: SpringerLink)
3. Juventix PRP + Biotin is now backed by a U.S. Notice of Allowance for a non-provisional utility patent. The kit’s integrated biotin-within-the-tube design provides a differentiated, closed-system solution specifically engineered for hair restoration.
4. PRiVIVE offers a needle-free, PRP- and exosome-compatible topical pathway. Dermal permeation data in human tissue models demonstrate platelet and protein delivery across intact skin without histologic damage, providing a rational alternative to acid-based “scalp peels.”
5. A regenerative, multi-modal protocol aligns better with patient safety, pharmacovigilance trends, and long-term practice reputation than leaning on caustic chemical trends or single-agent pharmacologic solutions.

Ready to Compare Juventix in Your Own Hands? Here’s How:

1. Request a FREE Biotin + PRP kit (just cover shipping & handling) ➜ https://juventix.com/sample-page/

Use the kit with your next appropriate hair-restoration candidate and consider pairing it with a custom PRP-enriched PRiVIVE™ Topical Serum as a take-home extension of care:
https://juventix.com/shop/privive-topical-serum-5-pack/

RESTORE, REVIVE, REGENERATE™ – JUVENTIX REGENERATIVE MEDICAL

References

1. EMA PRAC Meeting Highlights – Suicidal Thoughts with Finasteride (2025). European Medicines Agency. https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-may-2025 (European Medicines Agency (EMA))
2. ClinCalc DrugStats—Finasteride Prescription Volume (2022). https://clincalc.com/drugstats/Drugs/Finasteride (Wiley Online Library)
3. Gentile P., Garcovich S. Systematic Review of PRP in AGA (2020). Int J Mol Sci. https://www.mdpi.com/1422-0067/21/8/2702 (MDPI)
4. Verma K. et al. PRP vs Minoxidil RCT (2019). J Drugs Dermatol. https://jddonline.com/articles/a-randomized-control-trial-comparing-the-efficacy-of-platelet-rich-plasma-and-5-topical-minoxidil-for-the-treatment-of-androgenetic-alopecia-S1545961623P0905X (ScienceDirect)
5. Cruciani M. et al. PRP for Alopecia Meta-analysis (2023/2024). Aesthetic Plast Surg. https://pmc.ncbi.nlm.nih.gov/articles/PMC11073618/ (SpringerLink)
6. Pillai J.K., Mysore V. Role of LLLT in AGA (2021). J Cosmet Dermatol. https://pubmed.ncbi.nlm.nih.gov/35283601/ (ScienceDirect)
7. Zhang S. et al. Dermal-Papilla Exosome Study (2018). Stem Cell Res Ther. https://pubmed.ncbi.nlm.nih.gov/30924959/ (SpringerLink)
8. Liu C. et al. MDSC-Exosome AA Model (2018). https://pmc.ncbi.nlm.nih.gov/articles/PMC8829028/ (SCIRP)
9. Kwack M. et al. Exosomes Improve Hair Density (2024). https://link.springer.com/article/10.1007/s00266-024-04332-3 (SpringerLink)
10. Almohanna H.M. et al. Biotin & Hair Loss Review (2019). Dermatol Ther. https://pubmed.ncbi.nlm.nih.gov/30547302/ (SpringerLink)
11. PRP Therapy for Telogen Effluvium—Comprehensive Study (2024). J DERMIS (online). https://www.jdermis.com/full-text/platelet-rich-plasma-therapy-for-telogen-effluvium-a-comprehensive-evaluation-of-efficacy-and-safety (ScienceDirect)
12. Tejapira K. et al. PRP in AA Systematic Review (2022). https://pubmed.ncbi.nlm.nih.gov/36507528/ (Wiley Online Library)
13. Systematic Review PRP vs Minoxidil/Finasteride/Stem-Cells (2022). https://www.sciencedirect.com/science/article/pii/S235232042200102X (ScienceDirect)
14. Lee Y. et al. Exosome-Augmented PRP Meta-analysis (2022). https://onlinelibrary.wiley.com/doi/10.1111/jocd.15869 (SpringerLink)
15. PROSPERO-registered PRP Meta-analysis (2022). https://pubmed.ncbi.nlm.nih.gov/37533146/ (ScienceDirect)

Additional proprietary and technical information on Juventix PRP + Biotin Kit and PRiVIVE™ Topical Serum is drawn from U.S. patent documents and company clinical summaries.

Legal Disclaimer

The information contained in this article is provided for informational purposes only and should not be construed as medical or legal advice on any subject matter. You should not act or refrain from acting on the basis of any content included in this article without seeking medical, legal, or other professional advice. The contents of this article contain general information and may not reflect current legal developments or address your situation. We disclaim all liability for actions you take or fail to take based on any content of this article.

The post Is Glycolic Acid the Next Hair Loss “Hack” – or a Hidden Risk? appeared first on Juventix.

Overview Of Extracorporeal Shockwave Therapy

Extracorporeal shockwave therapy is widely used across musculoskeletal and soft tissue disorders. The two main device classes that are in clinical use are focused shock waves and radial shockwaves.

Focused Shockwave Devices

Focused shockwave devices produce a pressure wave that converges to an internal focal zone at a defined depth energy flux density. The focal depth can be controlled and can deliver higher peak pressures and is best suited to target deep lesions.

Radial Shockwave Devices

Radial shockwave devices generate a projectile that is produced by a pressure wave that spreads radially from the skin surface. Radial waves have maximal energy superficially and progressively less penetration with distance. They generally deliver lower peak pressures and lower energy flux density than focused devices.

Key Differences Between Focused And Radial Therapy

The key difference between radial and focused shockwave therapy is energy distribution and penetration, dose control, clinical handling, and the overall cost and logistics of the devices.

Clinical Applications Of Focused Shockwave Therapy

Focused shockwave therapy has a focal energy concentrated at a definable depth and is very useful for deep tendon insertions, bone tendon junctions, and focal calcifications and can deliver low to high energy flux density depending on the device. Focal extracorporeal shockwave is more precise in dosing, especially in the depth, and allows titration. Focal extracorporeal shockwave requires accurate localizations; sometimes utilization of ultrasound or palpation to target the focal spot is utilized.

Clinical Applications Of Radial Shockwave Therapy

Radial extracorporeal shockwave has the highest energy at or near the applicator’s surface with rapidly decreasing penetration, making it better for superficial structures and broader tissue areas such as superficial tendinopathies (plantar fasciitis). Radial extracorporeal shockwave’s dose is defined by air pressure and the number of pulses, and there is less precise focal dosing. Radial extracorporeal shockwave often is used for sweeping or broad application without an internal focal target.

Cost And Portability Comparison

Overall, focused shockwave devices are typically more complex and expensive, and radial devices are generally less costly and more portable. The device costs and availability may widely vary between manufacturers and regions.

Contraindications To Shockwave Therapy

Absolute Contraindications For Both Radial And Focused Extracorporeal Shockwave Devices

Malignancy in the treatment field or active tumor
Fetal area
Infection at target site
Open growth plates in children

Relative Contraindications To Shockwave Therapy

Coagulopathy or concurrent use of anticoagulants
Pacemakers or implantable cardiac devices
Areas of known major nerves or vessels

Side Effects Of ESWT

Transient pain during or after treatment, local erythema, swelling, petechiae, small hematomas, transient numbness or tingling. Serious complications such as tendon rupture are extremely rare according to expert consensus but have been reported. Overall safety profile is very favorable when the devices and the protocols are used appropriately.

How Do Shockwaves Work Clinically?

When shockwaves enter the human body, different mechanical effects will be generated at the interface of different tissues due to different contact media such as fat, tendon, ligament, and bone tissue, and finally, different forces will be generated on cells. In these forces, tensile stress can relax tissues. It promotes microcirculation while compressive stress can change the elasticity of cells and increase their ability to absorb oxygen.

Cellular and Therapeutic Mechanisms of Shockwave Therapy

For therapeutic purposes, extracorporeal shockwave therapy causes a large number of tiny bubbles to be created in the tissue which rapidly expand and burst under the action of the shockwave producing a high-speed fluid microjet and a shock effect. This cavitation effect is particularly effective in reopening occluded microvasculature and releasing soft tissue adhesions.

How Shockwave Therapy Reduces Pain and Inflammation

The exact mechanism of pain relieving and functional properties of extracorporeal shockwave therapy is not fully understood. Several studies have attempted to elucidate the mechanisms of shock waves from basic science and clinical studies have shown that energy released by extracorporeal shockwave therapy is able to stimulate pain receptors located in the skin, muscle, connective tissue, bone, and joints and activate unmyelinated C and delta fibers to initiate the pain control system and block nerve transmission resulting in analgesic effects. In addition, extracorporeal shockwave therapy has been shown to significantly downgrade the levels of IL-1, TNF-alpha, MMPs in degenerated joint tissues thereby reducing the local inflammatory response. Additionally, extracorporeal shockwave therapy also promotes the secretion of pain-reducing channels such as endorphins which inhibit the release of pain factors such as substance P and calcitonin-generated peptides which reduce peripheral nerve sensitivity and increase overall pain threshold levels.

Which ESWT Is Better Radial Or Focused?

Effectiveness of focused shockwave therapy versus radial shockwave therapy for noncalcific rotator cuff tendinopathies

Biomed Res Int 2021 Jan 9:2021:6687094 PMID 33506031

Background: The superiority of focused shockwave therapy versus radial shockwave therapy for treating noncalcific rotator cuff tendinopathies remains controversial. This study is aimed at comparing the effectiveness of focused shockwave therapy versus radial shockwave therapy for the management of noncalcific rotator cuff tendinopathies.

Conclusions: Both focused shockwave therapy and radial shockwave therapy are effective in patients with noncalcific rotator cuff tendinopathies. However, focused shockwave therapy proved to be significantly superior to radial shockwave therapy at long-term follow-up which is more than 24 weeks.

Comparative effectiveness of focused extracorporeal versus radial extracorporeal shockwave therapy for knee osteoarthritis

Int J Res Public Health 2022 Jul 24;19(15):9001 PMID 35897371

Background: Both focused extracorporeal shockwave therapy and radial extracorporeal shockwave therapy can alleviate symptoms in patients with knee osteoarthritis, but no clinical trials have directly compared focused extracorporeal shockwave therapy with radial extracorporeal shockwave therapy for knee osteoarthritis. This study aims to compare the effectiveness of focused and radial extracorporeal shockwave therapy on knee osteoarthritis.

Conclusion: Both groups showed significant improvement in secondary outcomes. However, the focused extracorporeal shockwave therapy group yielded greater improvement in the VAS score, WOMAC score, and six-minute walk test. Our results showed that focused extracorporeal shockwave therapy was more effective than radial extracorporeal shockwave therapy in improving pain and physical function in patients with knee osteoarthritis.

Radial versus focused extracorporeal shockwave therapy in lateral epicondylitis

J Phys Med Rehabil 2024 Oct 16;71(1):19-27 PMID 40270634

Objectives: This study aimed to compare the acute effects of radial extracorporeal shockwave therapy and focused extracorporeal shockwave therapy on pain, muscle strength, and function in patients with lateral epicondylitis.

Conclusions: Both groups showed a decrease in pain levels, but the effects were superior in the focused extracorporeal shockwave therapy group. However, the radial extracorporeal shockwave therapy group was found to present better results in terms of its effect on isokinetic muscle strength while focused extracorporeal shockwave therapy may be more effective in reducing pain, the radial extracorporeal shockwave therapy may be more effective in increasing the muscle strength in this group.

Authors note: The muscle group is not a focused target and larger in size. Radial ESWT is more diffuse. This explains the findings here.

Comparative effects of radial and focused extracorporeal shock wave therapies in coccydynia

J Phys Med Rehabil 2023 Feb 4;69(1):97-104 PMID 37201007

Objectives: This study was conducted to compare the effects of radial and focused extracorporeal shockwave therapy for patients with coccydynia.

Conclusions: Radial and focused extracorporeal shockwave therapy are both effective in treating coccydynia compared to sham extracorporeal shockwave therapy. However, radial extracorporeal shockwave therapy may be more effective in the treatment of coccydynia.

Authors note: Coccydynia is a larger area of treatment and not a focused area.

Focused extracorporeal shockwave therapy for the treatment of low back pain

Front Med 2024 Aug 29:11:1435504 PMID 39267973

Introduction: Low back pain is a common condition affecting up to 84% of people in their lifetime with a prevalence of 11.9% and a high reoccurrence rate within the first year. Furthermore, chronic low back pain syndrome has been described in up to 7%, making it a significant health and socioeconomic problem. Among non-operative treatment options, the recently used focused extracorporeal shockwave therapy devices generate waves that converge at a precise depth in the body thereby revealing the potential to affect pathology remotely from the contact surface. This article aims to present a systematic literature review with a critical discussion on treating low back pain using this modality.

Conclusion: Focused extracorporeal shockwave therapy is a modern physiotherapeutic method that can potentially treat a broad spectrum of conditions responsible for low back pain. Despite a small number of low evidence studies, there is sufficient data on the effectiveness and safety of this therapeutic modality and with future well designed trials the bias risks would be diminished and the indications for its use would expand.

Use of extracorporeal shockwave therapies for athletes and physically active individuals

Br J Sports Med 2024 Feb 7;58(3):154-163 PMID 38228375

Objective: To determine the efficacy of extracorporeal shockwave therapy and investigate outcomes following the use of extracorporeal shockwave therapy for athletes and physically active individuals.

Conclusion: Based on the studies, extracorporeal shockwave therapy may be effective alone in plantar fasciitis, lateral epicondylitis, proximal hamstring tendinopathy and as an adjunct to exercise treatment in medial tibial stress syndrome and osteitis pubis in athletes or physically active individuals. In most studies, athletes were allowed to continue activities and training and tolerated extracorporeal shockwave therapy with minimal side effects. The conclusion is that extracorporeal shockwave therapy may offer an efficacious treatment alone or as an adjunct to concurrent exercise therapy in selected sports related injuries and without major adverse effects. Focused shockwaves were used in these studies.

Extracorporeal shockwave therapy for tendinopathies around the hip and pelvis

HSS J 2025 Apr 23:15563316251332189 PMID 40292269

Discussion: Previous review has shown short or mid term results in this area due to the use of radial systems. This review looked at both focused and radial systems and outcomes.

Conclusion: Although extracorporeal shockwave therapy protocols for hip and pelvis related tendinopathies continue to vary, findings from this systematic review suggest that extracorporeal shockwave therapy can be used safely and effectively to treat lesions of the hip and pelvis region. Both focused extracorporeal shockwave therapy and radial extracorporeal shockwave therapy led to improvements in pain and functional outcomes with minimal side effects, however focused extracorporeal shockwave therapy provided significant longer-term outcomes when compared to the use of the radial devices.

Focused and Radial Systems Offered by Juventix

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Juventix offers both the Radial PhysioPRO and the FOCUS Shockwave System. As evidenced from the studies and literature, both devices are efficacious. However, the FOCUS Shockwave System is far more successful in attaining the desired result with more long term disease modification and remission. The focused system penetrates deeper, with higher energy making it the clear choice in musculoskeletal applications. In low back pathology, treating patients with pelvic pathology or patients with a higher BMI, the focused system far surpasses the radial system. Also, in calcific tendinopathies, especially in the pelvic region, the greater power of the focused system is needed to achieve disease remission.

Restore, Revive, Regenerate – Juventix Regenerative Medical

Regenerative regards,
Dr. Robert McGrath

The post Comparing Focused and Radial Shockwave Devices in Clinical Practice appeared first on Juventix.

Peripheral neuropathy is a clinical syndrome resulting from damage to the peripheral nervous system. Common symptoms are pain, numbness, tingling and motor dysfunction.

Current standard treatments are aimed at symptom control only. Orthobiologic treatments are currently being used due to their regenerative and healing capabilities.

Causes Of Neuropathy

Peripheral neuropathy has diverse etiologies:
Metabolic and endocrine disorders with diabetes being the most common.
Genetic disorders such as Charcot-Marie-Tooth disease (a hereditary disease that damages nerves in the legs and arms).
Toxic exposures especially to chemotherapy agents such as vincristine.
Infections such as HIV and leprosy.
Inflammatory/immunologic conditions such as Guillain Barre syndrome.
Nutritional deficiencies like B12 deficiency.
Physical trauma or compression of the nerves such as carpal tunnel syndrome.

Symptoms

Sensory: pain, burning, tingling, numbness, hypersensitivity.
Motor: muscle weakness, unstable gait.
Autonomic: blood pressure fluctuations, bowel and bladder dysfunction.

Orthobiologic Treatments Of Peripheral Neuropathy

Platelet Rich Plasma

Mechanism

Platelet Rich Plasma is an autologous concentrate, rich in growth factors, cytokines and bioactive proteins. These molecules modulate inflammation and support tissue regeneration.
A few of these growth factors include: EGF, VEGF, IGF-1 and TGF-beta.

Epidermal Growth Factor – is a small protein that acts as a signaling molecule telling cells to grow, divide and differentiate and triggers repair and cell survival.
Vascular Endothelial Growth Factor – this protein stimulates the growth of new blood vessels and lymphatic vessels.
Insulin Growth Factor-1 – in nerve tissue IGF-1 promotes cell growth and protects from breakdown.
Transforming Growth Factor Beta – is a multifunctional cytokine that regulates a wide range of cellular processes including cell growth and differentiation.

Clinical evidence

Animal studies demonstrate that PRP enhances Schwann cell support, remyelination and nerve regeneration in models of nerve damage.
A systematic review concluded PRP is more effective than conservative treatments for carpal tunnel syndrome in short and mid-term outcomes.
In diabetic peripheral neuropathy, PRP is more effective in improving pain, sleep quality and overall function when compared to pregabalin (Lyrica) or gabapentin (Neurontin).
In severe peripheral neuropathic cases (e.g., leprosy patients) about 39 out of 45 (87%) experienced 70% pain reduction greater than 3 months with PRP therapy.
In most studies, meaningful symptom relief and function improvements were noted with PRP over other treatments.

Stem Cells

Mechanism

Mesenchymal stem cells exert therapeutic effects via:
Anti-inflammatory and immunomodulatory cytokine release such as Interleukin-10 and TGF-beta and reducing proinflammatory mediators such as IL-1, IL-6 and TGF-alpha.
Migration to injury sites, trophic support and differentiation into neural or support cells.
Paracrine effects, including extracellular vesicles/exosomes carrying proteins, mRNA that promote neuronal regeneration.
In animal models with nerve injury mimicking diabetic neuropathy, MSC reduced hyperalgesia/allodynia and improved nerve function and conduction metrics.
Muse cells – a subpopulation of stem cells administered intrathecally achieved superior analgesic impact in animal studies.

One estimate in a non-peer-reviewed study suggested improvement in up to 80% of treated patients.

Exosomes (Derived From Mesenchymal Stem Cells)

Mechanism

Exosome therapy delivers regenerative signals by growth factors, cytokines and mRNA contained on them and this supports neuronal survival, reducing inflammation and enhancing neural regeneration.
These are derived from mesenchymal stem cells, so the effect is similar.
Exosomes are anti-inflammatory, support cell regeneration and differentiation into new tissue.

Exert Therapeutic Effects

Anti-inflammatory.
Bactericidal.
Promote angiogenesis.
Optimize collagen alignment.
Facilitate regeneration of neuronal tissue.

Exosome utility is strongly supported by clinical studies. Extracellular vesicles not only possess regenerative properties but serve as effective carriers for bioactive peptides and proteins.

Peptides

Peptides are short chains of two or more amino acids that are linked by peptide bonds. More than 7000 naturally occurring peptides that have critical roles in human physiology and performance have been identified. They work as hormones, neurotransmitters, growth factors, ion channel ligands or anti-infectives in the body. Peptides cause a cell signaling response that can have regulatory and rejuvenation actions on neuroendocrine immune function. Peptides can help the body recover from an injury or illness faster, lose weight more effectively, decrease inflammation and pain.

Peptides influence nerve health through several mechanisms beneficial in managing neuropathy. Some peptides promote the regrowth and repair of damaged nerve fibers – a process known as nerve regeneration. This regeneration capacity is an important area of current research for restoring nerve function. Many peptides also exhibit anti-inflammatory properties as inflammation contributes to nerve damage and neuropathic pain. By reducing inflammatory responses, peptides help protect existing nerve cells from further degeneration. This neuroprotective effect preserves nerve integrity. Peptides can also modulate pain signals offering relief from neuropathic pain. They interact with pain receptors or signaling pathways altering how pain is perceived. This multifaceted influence on nerve health – encompassing regeneration, anti-inflammatory actions, neuroprotection, and nerve and pain modulation – makes peptides a valuable area of study for neuropathic treatments.

Key Peptides In Neuropathy

ARA290
ARA290 is an eleven amino acid peptide derived from erythropoietin. Designed to avoid erythropoietin’s effects like increased red blood cell production, it selectively activates the innate repair receptor complex formed by the beta common receptor and the EPO receptor. This activation triggers anti-inflammatory pathways and promotes tissue repair, leading to a reduction in neuropathic pain symptoms and an increase in small nerve fiber density.

Nerve Growth Factor (NGF)
Nerve growth factor is a neurotrophin that supports the survival, growth and differentiation of neurons. NGF plays a role in the development and maintenance of the nervous system and is involved in the sensitization of pain pathways in neuropathic pain syndromes such as peripheral neuropathy.

BPC 157
BPC157 is a pentadecapeptide that originates from gastric juice. It is known for its regenerative and anti-inflammatory properties and has been studied for tissue repair. BPC157 promotes nerve regeneration, as shown in studies after peripheral nerve transection, and has neuroprotective effects influencing growth factors and promoting collagen formation.

TB-500
TB-500, also known as Thymosin Beta-4, is a synthetic 43 amino acid peptide. It promotes cell migration, blood vessel formation and tissue repair in nerve health. TB-500 enhances the repair of oligodendrocytes and astrocytes which support neurons and reduces glial scarring, a barrier to nerve regeneration. It also possesses anti-inflammatory effects that contribute to neurological recovery.

Cerebrolysin

Cerebrolysin is a mixture of enzymatically treated peptides and amino acids derived from pig brain. It is used clinically in some countries for neurodegenerative conditions due to its neurotrophic and neuroprotective effects. Cerebrolysin acts similarly to endogenous neurotropic factors, supporting neural networks and promoting nerve regeneration by stimulating pathways involved in brain plasticity and axon growth. It also protects the vascular system and reduces neuroinflammation.

Peripheral Neuropathy Treatment

PRP Therapy For Nerve Regeneration

Platelet Rich Plasma is an autologous blood-derived concentrate, rich in cytokines, growth factors and bioactive proteins. Platelet Rich Plasma is well known and studied for its regenerative potential. In peripheral neuropathy, PRP demonstrated positive effects on healing of nerve function as well as histological improvements on cut peripheral nerve injury models.
J Craniofac Surg 2017 Jan;28(1):e49-57 PMID 27893553

Stem Cell And Exosome Research

Stem cell-derived exosomes and mesenchymal stem cells have been studied in treating autoimmune and neurodegenerative diseases. Studies have shown mixed results. It was felt due to the size of stem cells, exosomes derived from stem cells would be a better smaller option. The exosomes were then tested and found to be efficacious. The testing found that stem cell-derived exosomes served as cell-free therapies for autoimmune and nervous system disorders.
ACS Nano 2019 Jun 25;13(6):6670-6688 PMID 31117376

Peptide Therapy And GLP-1 Benefits

Peptide therapy is currently under investigation in many research facilities. The results are very promising. GLP-1, which are currently being used for diabetes and weight reduction, have shown to have many other advantages. These agents have shown reversal of nephropathy, retinopathy and neuropathy. Well-designed studies are clarifying the benefit of these and other peptide compounds.
Diabetologia 2023 Oct;66(10):1832-1845 PMID 37597048

Juventix Regenerative Medical Solutions

PRP Kits And Devices For Neuropathy

Juventix Regenerative Medical provides high quality platelet rich plasma kits and devices for treatment of peripheral neuropathy. Our PRP kits are FDA cleared and designed for safety, sterility and effectiveness.

LED Activator For Enhanced Cytokine Release

Juventix Regenerative Medical provides a LED Activator, which utilizes polychromatic light to enhance the release of cytokines and growth factors from the alpha granules on the platelets. This method is especially important in treating diseases such as diabetic peripheral neuropathy.

Apollo Duet For Non-Invasive Delivery

Juventix Regenerative Medical offers the Apollo Duet. This innovative device employs the combination of electroporation and ionophoresis to drive molecules into the deeper aspects of the skin without the utilization of a needle. This technology would be extremely efficacious in those who have needle phobia or patients with peripheral vascular disease and subject to infections in the distal areas of the limbs.

Peptides For Research And Regenerative Innovation

Juventix Regenerative Medical is proud to offer peptides for research purposes. PubMed currently is listing 12,465 studies and articles concerning the use of peptides. Peptides are the wave of the future in medicine and regeneration. Along with exosomes, platelet rich plasma kits and devices and now peptides, Juventix is poised to assist the regenerative professional to achieve greater outcomes for their patients, especially those with neuropathy.

Restore, Revive, Regenerate – Juventix Regenerative Medical

Regenerative regards,
Dr. Robert McGrath

The post Juventix PRP for Peripheral Neuropathy appeared first on Juventix.

New data has just been released on the next generation of weight management and metabolic optimization peptides. This is generating weight loss numbers that were unheard of 5 years ago. In a new clinical study published in the New England Journal of Medicine, Cagrilintide was coadministered with Semaglutide in adults with obesity.

Groundbreaking Study on Cagrilintide and Semaglutide Combination

This study was a 68-week multicenter study enrolling adults without diabetes for weight loss. These patients had a body mass index of 30 or greater. The body mass index (BMI) is calculated by the weight in kilograms divided by the square of the height in meters. A total of 3417 participants with 2108 assigned to receive the combination of both semaglutide at 2.4 mg and cagrilintide at 2.4 mg, or semaglutide alone or cagrilintide alone. Although all participants using the combination or either drug alone had weight loss, the combination achieved superior results up to 30% loss of body weight. Side effects with the combination was 79.6% with the combination and 39.9% in the placebo group. These were mild and transient including nausea, vomiting, diarrhea and constipation.

How Cagrilintide Works to Enhance Satiety and Weight Loss

Cargrilintide is a long-acting amylin analogue, a synthetic cousin of the hormone amylin which is naturally secreted along with insulin from the pancreas. Amylin works in blood sugar regulation and satiety. It signals through the brain to “stop eating” and aids in blood sugar regulation.

Weight Loss Outcomes Compared: CagriSema vs Semaglutide Alone

In the study above, when semaglutide was paired with cargrilintide, all participants lost an average of 20.4% of their total body weight over the 68-week period of the study. Semaglutide alone produced a 15% reduction and cagrilintide alone reduced weight by 11-12%. This is a significant reduction when combined and the researchers theorized that each works at the receptor level.

Mechanisms of Action: GLP-1 and Amylin Pathways

GLP-1 agonists increase insulin secretion and suppress glucagon. They also slow gastric emptying making the patient feel full for a longer period after eating. Cagrilintide acts on the amylin pathway, delivering satiety signals directly to the brain. It also retards gastric emptying rates. The side effects are similar to the GLP-1 medications, but it has been reported that cagrilintide can cause an emotional flat affect. The dosage is .25mg 2-3 times a week with the GLP-1 and titrate up.

Retatrutide and Future Triple Agonist Therapies

When added to Retatrutide, the triple agonist, this combination should reduce weight by 30-40%. This combination is currently under investigation. Initially, the Glucagon like peptide -1 (GLP-1) was introduced then the Dependent Insulinotropic Polypeptide Dual Agonist (GIP) and finally the triple action of Retatrutide which adds the glucagon receptor agonists.

Study

Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
Published June 22, 2025, DOI:10.1056/NEjMoa2502081 PMID 40544433
Background: Semaglutide at a dose of 2.4mg has established weight loss and cardiovascular benefits and Cagrilintide at a dose of 2.4 mg has shown promising results in early phase trials, the efficacy of the combination known as CagriSema on weight loss in persons with either overweight or obesity is unknown.
Conclusion: cagrilintide-semaglutide provided significant and clinically relevant body weight reductions in adults.

Study

Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
N Engl J Med 2025 Jun 22 PMID 40544432
Background: Cagrilintide and Semaglutide have been each shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide for weight management in adults with type 2 diabetes.
Conclusions: Once weekly cagrilintide semaglutide resulted in a significantly lower body weight in adults with type 2 diabetes and obesity.

The Impact of Weight Loss on Muscle Mass and Skin Laxity

The amount of weight loss that can be provided by this combination of peptides is beyond significant. Ultimately, there will be a huge reduction in diabetes, cardiovascular disease, hypertension, strokes and other major diseases. However, there will be other consequences to this amount of weight reduction. With weight reduction, many patients lose an appreciable amount of muscle mass unless weight training is part of the overall protocol. Large weight reduction, with loss of muscle equates into loose skin, obvious stretch marks, creepy skin, and visible cellulite. Jelly Roll, the country rocker, recently formally announced his major weight loss and plans for needed plastic surgery to remove loose skin. With millions of Americans on GLP-1 meds and losing weight, not every patient can afford to obtain plastic surgery.

What Are the Alternative Options for Loose Skin, Fat Pockets and Striae?

Platelet Rich Plasma

Platelet Rich Plasma is an autologous blood concentrate that is rich in cytokines, growth factors and bioactive proteins. PRP has been used in all fields of medicine and is well established for its regenerative capabilities. In striae distensae, which are dermal scars associated with atrophy of the epidermis, PRP is extremely effective. Biopsies taken after the use of PRP on stretch marks show collagen and elastin fibers were increased.

Study

Platelet Rich Plasma Versus Tretinoin in Treatment of Striae Distensae: A Comparative Study
Dermatol Surg 2018 May;44(5):697-704 PMID 29701622
Objective: To evaluate the effect and safety of intralesional injection of platelet rich plasma versus topical tretinoin in the treatment of SD.
Conclusion: PRP injection and topical tretinoin are safe for the treatment of SD, but PRP is more effective, and it gives better therapeutic response than tretinoin.

PhysioPRO Shockwave Therapy System

Extracorporeal shockwave therapy (ESWT) is a noninvasive treatment option for improving skin laxity and body contouring. It utilizes acoustic waves to stimulate collagen production and enhance skin elasticity. When employed in a targeted area, high energy waves promote blood circulation and cellular repair. The collagen and increased vascularity can tighten skin over time. ESWT is effective for sagging skin in areas such as the abdomen, thighs and triceps. It can also assist in reducing the appearance of cellulite. Results vary by the individual and take several weeks to become noticeable as collagen builds. Multiple treatments are needed often spaced weeks apart and side effects to the therapy with the shockwave are minimal.

Study

Cellulite and Focused Extracorporeal Shockwave Therapy for Non-invasive Body Contouring: A Random Trial
Dermatol Ther 2013 Dec 3;(2):143-155 PMID 24297647
Conclusion: ESWT and gluteal strength training improved cellulite and contoured the buttock area by 24% over control groups.

Radiofrequency

Radiofrequency skin tightening is another nonsurgical treatment to treat sagging skin. Radio frequency devices use safe levels of low frequency electromagnetic waves to generate heat. The heat penetrates deep into the layers of the skin. There, it stimulates new skin regeneration by stimulating the production of collagen and elastin. Collagen and elastin provide the skin cells with more strength and flexibility. This process results in the skin regaining its prior shape and feel. Radiofrequency improves the skin tone, texture and firmness and reduces the skin’s wrinkles, fine lines and sagginess. RF is utilized in body contouring especially in the face, neck, arms and hands.

Study

Noninvasive Radio Frequency for Skin Tightening and Body Contouring
Cutan Med Surg 2013 Mar;32(1):9-17 PMID 24049924
RF thermal stimulation is believed to result in a microinflammatory process that promotes new collagen. By manipulating skin cooling, RF can be used for heating and reduction of fat. Currently, the most common use of RF based devices are to noninvasively manage and treat skin tightening of lax skin (including sagging jowls, abdomen, thighs and arms) as well as wrinkle reduction, cellulite improvement and body contouring.

Low Level Laser Therapy

The use of low-level laser therapy (LLLT) is called photobiomodulation. Photobiomodulation therapy is defined as a form of light therapy that utilizes nonionizing light sources in the visible (400-700) electromagnetic spectrum. Gaining popularity in clinical practice for body contouring, the treatment protocols vary depending on the adipose makeup of the patient.

Study

Photobiomodulation Therapy for Improvement of Body Contour: A Retrospective Study on Middle Eastern Participants
Iran J Public Health 2024 Aug;53(8):1858-1863 PMID 39415875
Background: The rising demand for body contouring and concerns about side effects of invasive surgical procedures have led to advances in providing new noninvasive alternative methods for weight reduction. The current retrospective study investigated the safety and efficacy of photobiomodulation technology in reducing local obesity in Middle Eastern participants.
Conclusion: This study demonstrated the effectiveness and safety of photobiomodulation in reduction of circumferential size in abdomen, buttock, thigh and arm areas in Middle Eastern participants with high patient satisfaction an acceptable safety profile.

Juventix Regenerative Solutions for Post-Weight Loss Skin Tightening

These are a few of the options available for the treatment of loose skin and pockets of fat deposits that occur after a significant weight reduction. Surgery is not the only option. Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility and effectiveness and are currently being utilized by regenerative professionals around the world. However, Juventix Regenerative Medical has so much more to offer. In the treatment of body contouring, the PhysioPRO is a clinical grade extracorporeal shockwave device that induces intracellular and extracellular reactions to regenerate and tighten tissues.

Juventix Regenerative Medical offers the Apollo Duet. This device incorporates three aesthetic applications, electroporation and ionophoresis to penetrate the skin without the use of a needle and achieve penetration of serums into the deeper layers of the skin. The second modality is 4th generation radio frequency to stimulate collagen and elastin production to tighten loose skin areas.

Juventix Regenerative Medical also offers the Gemstone Laser. This device generates 532 wavelength light to stimulate cellular lipolysis. This removes stubborn fat deposits by working at the cellular level to open the fat cells and their contents are dissipated naturally by the body. This results in body tightening and sculpting. All without needles or pain. Improvements can be visualized in as little as two treatments.

Dramatic weight loss is now commonplace and so is loose, lax skin with pockets of fat.

Juventix Regenerative Medical has the solutions.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,

Dr. Robert McGrath

The post Next-Gen Weight Loss Medications & PhysioPRO Shockwave Therapy for Loose Skin appeared first on Juventix.

Facial skin is one of the first regions to show signs of aging and environmental exposure. These changes include thinning of the epidermis, reduction in dermal collagen, loss of skin elastic properties and the appearance of fine lines and wrinkles.

Platelet Rich Plasma is an autologous blood derived concentrate, rich in cytokines, growth factors and bioactive proteins. These growth factors stimulate tissue regeneration and collagen production. With extremely low side effects and patient tolerability, platelet rich plasma has become an increasingly popular option in aesthetic dermatology. Platelet Rich Plasma offers a science proven approach to facial skin rejuvenation. PRP stimulates the natural regenerative pathways with minimal recuperative time and minimal side effects. It is a versatile and safe option for regenerative professionals and patients seeking a natural gradual improvement in aging skin.

Mechanism of Action

Platelet Rich Plasma contains a concentration of growth factors and cytokines that modulate tissue repair and regeneration. Some of these factors are:

• Platelet Derived Growth Factor
• Transforming Growth Factor-beta
• Vascular Endothelial growth Factor
• Epidermal Growth Factor
• Insulin Like Growth Factor

These have been 300 of these molecules identified and some studies estimate there could be as many as 3000 in total.

PRP’s Regenerative Effects

These growth factors work synergistically and promote:

• Fibroblast activation and proliferation
• Neocollagenesis which is new collagen formation.
• Angiogenesis which is new blood vessel formation.
• Extracellular matrix formation

Once activated, platelets degranulate and release these factors and a localized cascade reaction occurs which begins the regenerative process. Platelet Rich Plasma acts as a chemotactic stimulus for stem cells and promotes healing and tissue regeneration by the modulation of inflammation and the action of fibroblasts in the dermis.

PRP Delivery Methods and Skin Penetration

Platelet Rich Plasma is typically delivered by:

• Intradermal injection which deposits platelet rich plasma directly into the dermis.
• Micro needling which enhances transdermal absorption of PRP by creating microchannels through the stratum corneum. This facilitates the transdermal penetration.
• Electroporation and iontophoresis where electric current in a continuous pulsed manner reversibly opens the cell wall and PRP is driven down by electro-magnetic polarization.
• Sonification where sonic waves disrupt the stratum corneum and PRP enters the deeper skin layers.
• Chemical electroporation where special serums chemically drive the PRP into the tissues over time.

Combination techniques are often used to improve distribution and the depth of penetration depending on the tissue.

Patient Comfort and Recovery

Pain levels vary with the individual and the technique employed.

• Injections – patients report mild to moderate discomfort mitigated by topical anesthetics.
• Micro needling – very well tolerated with some stinging or burning reported.
• Recovery period – again this is variable depending on the individual. Usually, redness and minor swelling may last 1–3 days.

Side Effects and Safety Profile

As an autologous blood derived concentrate, platelet rich plasma minimizes the risk of any immunologic reactions. Reported side effects are usually mild and transient. Such as:

• Bruising and mild swelling at the treatment site.
• Redness and mild inflammation.
• Mild discomfort and a tight feeling of the skin.

No significant adverse effects have been reported with repeated use even over several years.

Poor technique may result in prolonged erythema or uneven texture. This is not caused by platelet rich plasma.

Duration of Results and Longevity

Every person is different as is the skill of the professional. Concurrent diseases effect the results and duration as does smoking and drug use. Environmental factors also effect the duration of the results.

• Improvement in hydration and skin texture typically seen in 2 weeks.
• Noticeable reduction in fine lines and wrinkles with increased firmness in 6 weeks
• Optimal effects often peak at 3 to 6 months.
• Longevity can last 6 to 12 months with longer durations with repeated use.

Clinical Evidence Supporting PRP for Facial Rejuvenation

Study: Synergistic Effects of PRP and Hyaluronic Acid

Aesthet Surg J 2021 Jun 14;41(7);NP854-NP864 PMID 33534905

Objectives: The aim of this study was to assess and investigate the synergistic effect of hyaluronic acid and autologous platelet rich plasma injections on facial skin rejuvenation.
Conclusions: Combining platelet rich plasma and hyaluronic acid is a promising treatment for facial rejuvenation with a highly significant improvement in facial appearance and skin elasticity compared with PRP or HA alone.

Study: Pure PRP Injections – Anti-Aging Evaluation

J Cosmet Dermatol 2019 Aug;18(4):985-995 PMID 30350908

Background: During skin aging, a degeneration of connective tissue and decrease in hyaluronic acid occurs. Since platelet rich plasma contains growth factors and various cytokines, it was hypothesized that it could play a role in fibroblast activation and type 1 collagen expression in human fibroblasts.

Objectives: This study was performed to assess the efficacy of autologous platelet rich plasma injections for facial skin rejuvenation, measured by biometric instrumental evaluations and patient reported outcomes.

Conclusion: After a series of 3 platelet rich plasma injections at 6 month follow up resulted in significant skin rejuvenation as demonstrated by biometric parameters and confirmed by patient self-assessment scores.

Study: Molecular Effects of PRP on Wrinkled Skin

Exp Ther Med 2020 Feb 17;19(4):3024-3030 PMID 32256789

Objectives: Autologous serum platelet rich plasma has been used to rejuvenate wrinkled and aged skin for years; however, the molecular mechanism for the positive results of PRP on the skin remains unclear. The present study aimed to clarify the potential molecular mechanisms for the role of platelet rich plasma in wrinkled and aged skin rejuvenation and provide evidence for future clinical applications.

Conclusion:
Ultraviolet light is the primary stress that causes oxidative stress in the skin. This reaction is initiated by reactive oxygen species and eventually results in premature skin aging by inhibiting transforming growth factor beta activity, inducing MMP expression and activation the TOR signaling pathway, culminating in the inhibition of autophagy.

PRP is involved in autophagy and inhibits UV induced MMP-1 and tyrosinase upregulation to protect the skin from photoaging.

PRP also induced expression of factors that improved skin elasticity.

Platelet Rich Plasma treatment directly implants a variety of active growth factors into the aging skin. These factors change gene expression in skin cells, promote skin cell proliferation and differentiation and rearrange the structure of skin tissues. PRP injections are effective in improving skin conditions and protecting skin from photoaging and thus have broad applications in anti-aging skin repair.

Study: Use of Platelet Rich Plasma for Skin Rejuvenation

Skin Res Technol 2024 Apr 22;30(4):e13714 PMID 38650371

Objective: Platelet Rich Plasma is recognized as a safe and effective therapy for regenerative skin healing and rejuvenation, utilizing autologous blood enriched with various growth factors. This review aims to assess the efficacy of PRP treatment for skin rejuvenation.

Conclusion:
Analysis revealed that PRP treatment led to significant enhancements in multiple facial parameters after one to three sessions. Improvements were noted in skin pore size, texture, wrinkle reduction, pigmented spots, collagen density, hyaluronic acid levels and protection against ultraviolet damage. Combining PRP with hyaluronic acid demonstrated a synergistic effect particularly enhancing skin elasticity and firmness. Incorporating both physical and biometric data for assessment proved superior to relying solely on physical observations for evaluating skin quality and structural changes.

This study underscores the efficacy of PRP monotherapy for skin rejuvenation. Heightened awareness and advancements in technology have contributed to the emergence of higher quality, less biased studies supporting PRP as reliable and safe therapeutic option for skin rejuvenation.

Juventix Regenerative Medical: Industry Leaders in PRP Technology

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility and effectiveness. Our kits are scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

Advanced PRP Activation Technology

Juventix Regenerative Medical offers a patented LED Activator to degranulate the platelets and begin the regenerative process. The activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA.

This activation should always be accomplished after the gentle swirl of the centrifuged product to maximize the number of captured platelets.

Platelet Rich Fibrin and Advanced Device Solutions

Juventix Regenerative Medical supplies a patented Bio-Incubator to transform the Platelet Rich Plasma into an Injectable Platelet Rich Fibrin. The Platelet Rich Fibrin, commonly called the “second generation of platelet products” has different cytokines and growth factors than the original PRP. These different cytokines provide an anti-inflammatory microenvironment and can be used confidently in inflammatory conditions.

Juventix Regenerative Medical supplies the Radiance RF Advanced Radiofrequency Micro Needling Device. This device is the most up to date RF in the marketplace. It is a cutting edge subdermal adipose remodeling device that synergistically combines micro needling with radiofrequency energy. This dual action approach enables the regenerative professional to deliver precise application into the deeper skin layers effectively stimulating collagen and elastin production. The needles used are the most advanced in the aesthetic arena. This device has been proven to enhance the appearance of saggy skin, fine lines and wrinkles especially in the face and neck area.

Juventix Regenerative Medical offers the Apollo Duet for multiple skin and musculoskeletal applications. This is a needle free treatment using electroporation and iontophoresis followed by radiofrequency. Since no needles are used, there is minimal, if any, healing time needed after treatments and this equipment can be utilized by unlicensed assistants in the spa facility as a Class 1 medical device. The benefits of the Apollo Duet are improvements in skin texture and firmness, minimization of solar damage, reduction of fine lines and wrinkles and overall tightening of areas of skin laxity. All without utilization of a needle!

Transform Your Aesthetic Practice with Juventix

Juventix Regenerative Medical has a vast array of products, devices and services tailored for the regenerative professional. From Platelet Rich Plasma Kits and processing devices to our newest additions for needleless aesthetic care, Juventix offers the newest “cutting edge “products for our regenerative collaborators. The regenerative marketplace is exploding and transforming daily for both men and women. With our premier line of products and our experienced staff Juventix will aid and guide any regenerative professional in providing enhanced outcomes and increased patient satisfaction.

RESTORE. REVIVE. REGENERATE. — JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,
Dr. Robert McGrath

The post Face Aging and Platelet Rich Plasma appeared first on Juventix.

Polydeoxyribonucleotide (PDRN) is a DNA derived biopolymer with regenerative, anti-inflammatory and tissue repairing properties. Extracted primarily from the sperm of salmon species, PDRN is fast becoming the new darling of aesthetic and regenerative medicine. This molecule has been widely used in South Korea and has received accolades in the aesthetic marketplace. However, in The United States, PDRN is not well known. This article will provide an overview of the biologic function, aesthetic benefits and safety concerns as well as evidence supporting the clinical efficacy of PDRN.

Polydeoxyribonucleotide is a low molecular weight DNA fragment composed of deoxyribonucleotides derived from fish sperm. Commonly used species are rainbow trout (Oncorhynchus mykiss) or chum salmon (Oncorhynchus keta). It is classified as a biologic and considered a DNA based compound. PDRN can promote tissue repair, regeneration and angiogenesis.

PDRN is a mixture of DNA fragments that function together to stimulate the A2A adenosine receptor, modulating inflammation, promoting cell proliferation and supporting tissue repair pathways of DNA synthesis.

Mechanism of Action

Polydeoxyribonucleotide is not present in the human body. It mimics endogenous nucleotides and participates in tissue repair through several biologic pathways.

Activation of Adenosine A2A Receptors

This pathway results in anti-inflammatory signaling reducing inflammatory cytokines such as TNF-alpha and IL-6. A2A receptors are a type of adenosine receptor that plays a significant role in the regulation of immune function, inflammation, and neurological function.

DNA Salvage Pathway

PDRN provides needed nucleotides in the formation of DNA synthesis. This is critical in rapidly regenerative tissue. It augments the action of the fibroblasts and keratinocytes.

Stimulation of Fibroblast Growth and Collagen Production

Enhances the integrity of the extracellular matrix and improved dermal elasticity.

Angiogenesis

PDRN supports the formation of new vasculature in regenerating tissues.

Sources and Extraction

PDRN is harvested from the sperm of fish especially salmon due to their DNA similarity to humans and extremely low immunogenicity. The DNA is purified through a process of enzymatic hydrolysis and heat processing. This ensures the removal of specific proteins and immunogenic components. The salmon sperm DNA is the preferred choice due to its safety, scalability and high nucleotide yield. Salmon sperm and the processing makes it useful for medical and cosmetic applications.

Despite PDRN being derived from salmon sperm, it does not contain proteins responsible for fish allergies. The common culprit responsible for fish allergies is parvalbumin. Purification removes immunogenic proteins making it generally safe for individuals with fish allergies. However, in highly atopic or allergic patients, supervision is always advised.

Aesthetic Medicine and PDRN

Skin Rejuvenation
Topicals and injectable applications improve dermal thickness.
Topicals and injectable applications reduce fine lines and wrinkles.
Overall, applications brighten skin and improve texture.
Studies have proven enhanced collagen production and increased skin hydration.

PDRN can and is often combined with hyaluronic acid, growth factors, exosomes, platelet rich plasma and peptides to augment tissue regeneration. This is particularly noted in regenerative facial treatments and injectables.

Advantages in Aesthetic Use

• Non-immunogenic and safe for repeated usage.
• Anti-inflammatory and beneficial in acne and rosacea prone skin.
• Tissue regeneration promoting the synthesis of collagen and elastin.
• Post procedure recovery is enhanced, reducing downtime and augmenting results.
• Clinically proven visible improvement in wrinkles and skin elasticity especially in the periorbital area after a series of treatments.

Side Effects

Significant side effects are rare.
Mild transient erythema or swelling at the injection site.
Allergic reactions are extremely rare due to the high purification process and standards.

In wound healing, deoxyribonucleotide has been studied and proven to promote wound healing by promoting angiogenesis and epithelial regeneration. It is especially useful in post laser or micro needling recovery. PDRN reduces scar formation when utilized post treatment.

PDRN is clinically proven, safe, and effective agent for tissue regeneration and aesthetic applications. It is firmly solidified as a staple in Korean skincare and global aesthetic medicine due to the multifaceted roles in wound healing, anti-inflammation and dermal rejuvenation.

Clinical Studies on PDRN

PDRN prevents SIRT1 Degradation by Attenuating Autophagy During Skin Aging
PLoS One 2025 May 9;20(5):e0321005 PMID 40343916

Skin aging is a complex process influenced by many factors, such as ultraviolet radiation from the sun and oxidative damage. In this study, we utilized UVB induced photoaging or H2O2 induced oxidative stress models to explore the effects of PDRN on anti-aging. The findings revealed that keratinocytes exhibited significantly reduced cell proliferation and increased cell apoptosis when exposed to UVB or H2O2. Findings indicated that PDRN protects cells from UVB and H2O2 damage. We hypothesized that PDRN promotes cell proliferation by modulating the expression of key genes.

Silent information regulator 1 (SIRT1) plays an essential role in antioxidant, anti-apoptotic and senescence process. In this study, PDRN significantly upregulated SIRT1 expression at protein levels and attenuates stress granules in the cytoplasm, particularly under UVB and H2O2 stimulation, implying PDRN decreases skin aging by promoting the expression of SIRT1.

Human skin aging is characterized by thinning, fragility and hyperpigmentation. In order to verify the anti-aging effect of PDRN on the human skin, we administered UVB radiation to mice to stimulate the characteristics of human skin aging. H&E results showed that UVB radiation induced skin atrophy, thinning of the epidermal layer and cellular reduction in the skin of mice but the aging skin could be restored to the same level as that of controls after treatment with PDRN. This implies that PDRN can greatly alleviate the skin photodegradation induced by UVB.

Conclusion: This study demonstrates that PDRN effectively inhibits the aging of keratinocytes by upregulating Silent Information Regulator 1 (SIRT1) expression and reducing nuclear autophagy when exposed to UVB or H2O2 induced senescence. These findings reveal the cellular anti-aging properties of PDRN and provide insights into the mechanism underlying its potential as a natural ingredient in skincare products.

Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
Pharmaceuticals 2021 Oct 29;14(11):1103 PMID 34832885

This study investigated the use of PDRN in wound healing.

Conclusion: Regarding safety, acute and chronic toxicity studies in mice were undertaken to evaluate the repeated systemic administration of PDRN which showed no toxic effect in the brain, liver, lungs, skeletal muscle and heart and did not cause mortality. In this clinical study on the effects of PDRN on the healing of chronic diabetic wounds, safety and tolerability were excellent.

The combination with bioactive materials including hydrogels, scaffolds, nanofibers and films enhance the pharmacological activity of PDRN and offer important advantages in wound healing and tissue engineering.

The Effectiveness of Polynucleotides in Aesthetic Medicine: A Systematic Review
J Cosmet Dermatol 2025 Feb;24(2):e16721 PMID 39645667

Background: Polynucleotides, popular in bio revitalization, show promise in the current sphere of aesthetic medicine due to their regenerative properties, previously used in wound healing. The aim of this review was to synthesize the existing literature, focusing on the effectiveness of PDRN in aesthetic medicine, which is concentrated on skin rejuvenation by providing patients with multiple benefits and the least side effects.

Conclusion: Polynucleotide injections have shown promising outcomes in reducing wrinkles, improving skin texture and enhancing elasticity with statistically significant results in several studies. While side effects are generally mild and transient, patient satisfaction is moderate to high suggesting PDRN treatment is well tolerated and effective cosmetic intervention.

Juventix Regenerative Medical: Advanced PDRN Delivery

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Juventix is now proud to offer the LuxsQueen core serum line of products. These encompass anti-aging, acne and skin brightening lines of products. Polydeoxyribonucleotide is included in these serums.

Juventix Regenerative Medical has devices that will deliver these serums into the skin without the use of needles. The Apollo Duet device utilizing a combination of electroporation and iontophoresis to drive products to lower skin surfaces. Privive serum which can be combined with exosomes, platelet rich plasma and other biologics to chemically absorb into the lower skin layers and to speed recovery post procedure.

Juventix Regenerative Medical has answered the need for pain free, needle free delivery options for use by all members of the med spa community. When combined with LuxsQueen serums, exosomes, peptides or platelet rich plasma, excellent results are obtained leading to greater outcomes with enhanced patient satisfaction.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,
Dr. Robert McGrath

The post Polydeoxyribonucleotide (PDRN): The New Face in Aesthetics appeared first on Juventix.

Pre-Aging Skin Treatment refers to the premature onset of visible and functional signs of aging in younger individuals, typically between 25-35 years of age. This condition is influenced by genetic, environmental and lifestyle factors that accelerate skin aging before chronological markers would suggest.

What is Pre-Aging?

Skin aging is traditionally associated with chronological progression however a growing number of individuals in their 20’s and 30’s are presenting with dermal deterioration. Dermatologists and aestheticians have termed this condition, pre-aging. This is characterized by loss of elasticity, dull complexion, fine lines and uneven texture.

Causes of Pre-Aging

Intrinsic Factors

Genetic predisposition with reduced collagen and elastin production
Hormonal imbalances with elevation of stress related cortisol levels

Extrinsic Factors

Ultraviolet exposure and photoaging of the skin.
Pollution induced oxidative stress.
Skin care neglect or overuse of harsh chemical treatments.
Blue light chronic exposure.
Lifestyle causes such as poor nutrition, lack of exercise, smoking, use of drugs etc.

Physical Changes Seen in Pre-Aging

1. Fine lines, wrinkles and expression wrinkles. These are caused in part due to collagen and elastin degradation and lack of production. This causes less dermal support developing crows’ feet, frown line, and forehead creases.
2. Loss of radiance and glow caused by decreased microcirculation and lack of retained moisture. This makes the skin appear dull, less vibrant and fatigued.
3. Dull and uneven skin tone caused by accumulation of dead skin cells. This reduced cell turnover leads to a poor dull complexion. The poor cell turnover rate can cause early hyperpigmentation areas and sunspots due to UV exposure and insufficient photoprotection.
4. Enlarged pores and early skin texture changes because of sebaceous gland activity and environmental damage. These are found commonly on the nose and cheeks. Skin appears rough due to barrier impairment and decrease desquamation.
5. Dryness and dehydration as a result of a compromised skin barrier. This results in tightness, flakiness and increased sensitivity. This is often complicated with harsh skincare products.
6. Vascular changes and redness with mild telangiectasias and persistent erythema on the nose and cheek areas due to chronic UV light exposure.
7. Periorbital changes are common in pre-aging with dark circles, puffiness and thinning skin in the orbital area.
8. Glycation is common with loss of suppleness and an overall yellowish tone. This is a result of advanced glycation especially in individuals with high sugar in their diets or oxidative stress with high cortisol levels.
9. Changes in the skin biome and barrier integrity leads to a rosacea like appearance and commonly treated with acne medications which makes the condition worse.

The above are some of the physical signs of pre-aging but not all. They are early biomarkers for significant future aging of the skin and should be delt with promptly to prevent further damage.

Pre-Aging Treatments and Their Mechanisms at the Cellular Level

The goal of treatment of pre-aging is to preserve youthful skin and function, restore homeostasis and prevent and reverse oxidative, inflammatory and structural damage before it becomes irreversible. These are some of the key treatment categories and their cellular mechanisms of action.

Sunscreens and Physical Photo protectants

(eg. Zinc oxide, titanium dioxide, tinosorb)

These agents reduce formation of reactive oxygen species and inflammatory mediators in keratinocytes and fibroblasts. They inhibit metalloproteinase expression which leads to the breakdown of collagen. They also block UVA/UVB radiation preventing the DNA damage caused by this spectrum of light.

Barrier Repair and Moisturizing Agents

(eg. Ceramides, hyaluronic acid, squalene, panthenol)

These agents help rebuild the stratum corneum lipid matrix preventing water loss. Hyaluronic acid binds up to 1000x its weight in water, expanding the extracellular matrix volume and improving hydration. These agents support the skin junction integrity while enhancing keratinocyte function and communication.

Antioxidants

(eg. Vitamin C, Vitamin E, Niacinamide, Resveratrol, Ferulic Acid)

These agents neutralize free radicals such as ROS generated by UV pollution and inflammation which causes DNA damage and lipid peroxidation. Vitamin C stimulates collagen synthesis as a cofactor for prolyl and lysyl hydroxylase in collagen formation. They enhance barrier function by reducing oxidative stress and damage to keratinocytes and fibroblasts. Finally, they downregulate inflammatory cytokines such as IL-6 and TNF-alpha which both cause matrix breakdown.

Retinoids and Retinol Alternatives

(eg. Retinol, tretinoin and bakuchiol)

These compounds bind and upregulate collagen and elastin gene expression in dermal fibroblasts. They normalize the function of the keratinocytes reducing hyper keratinization. They bind to nuclear receptors in skin cells modulating gene transcription. Bakuchiol mimics retinoid activity but also possesses anti-inflammatory and antioxidant effects and does not activate retinoid receptors. This decreases skin dryness and irritation as seen with most retinoids.

Peptides and Growth Factor Mimetics

(eg. Acetyl Dipeptide 31 Amide, Palmitoyl Tripeptide 1, Matrixyl, GHK-Cu)

These are cellular peptides which stimulate fibroblasts to increase collagen synthesis. Peptides reduce matrix metalloproteinases that degrade collagen under oxidative or UV stress. They maintain epidermal integrity by keratinocyte proliferation and promote wound healing. Acetyl Dipeptide 31 Amide modulates neurogenic inflammation reducing cortisol induced cell damage and upregulates stress protective proteins.

Micro needling and Low-Level Laser Light Therapy (LLLT)

Micro needling induces a controlled micro-injury that stimulates the wound healing cascade. In turn, activation of fibroblasts migration and TNF-beta signaling occurs increasing collagen and elastin deposition. Micro needling enhances topical product penetration through the microchannels made in the stratum corneum and below.

LLLT using photo biomodulation by red or near infrared light enhances mitochondrial ATP production in the dermal cells. This increases cytochrome c oxidase activity supporting repair and reducing oxidative stress.

The Power of Acetyl Dipeptide 31 Amide and Bakuchiol

The most recent and studied combination for pre-aging is Acetyl Dipeptide 31 Amide and Bakuchiol. They have synergistic effects in the treatment of this condition.

Acetyl Dipeptide 31 Amide

1. Acts on neuromodulator pathways reducing inflammation and cortisol related skin damage.
2. Reduces sensory neuron stimulation minimizing redness and sensitivity.
3. Increases epidermal stem cell expression.

Bakuchiol

1. Stimulates collagen types 1, 3, and 4 expression without binding retinoid receptors.
2. Reduces early pigmentation changes by improving melanin dispersion.
3. Reduces lipid peroxidation and inflammation in fibroblasts.

Both ingredients, reduce oxidative and inflammatory damage while promoting fibroblastic activity and overall skin homeostasis. These compounds delay the transition from pre-aging to aging skin while preserving youthful appearance and skin structure.

Cellular Benefits of Treating Pre-Aging Early

The treatment of pre-aging works at the cellular level to perform the following:

1. Protect against oxidative stress.
2. Enhance collagen synthesis and matrix repair.
3. Improve barrier function and increase hydration.
4. Reduce inflammation and hormonal signaling.
5. Promote cell turnover and epidermal regeneration.

The Importance of Early Detection and Treatment

The pre-aging population represents both a challenge and an opportunity to impact the course of skin aging. Early interventions can delay the more advanced stages of this disease. Studies show that more free radicals are generated in younger skin after exposure to agents such as UVA than in older skin. However, younger skin is more responsive to treatments and prevention. Therefore, early detection and therapy is mandatory in this group of individuals to reduce the current epidemic of pre-aging skin.

Studies

Counteracting Skin Aging in Vitro by Phytochemicals
J Cell Mol Med 2025 Apr;29(7): e70530 PMID 40181572

Combined Multilevel Anti-Aging Strategies and Practical Applications of Dermocosmetics in Aesthetic Procedures
J Eur Acad Dermatol 2024 Jul;38 Supp 4:23-35 PMID 38881448

A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging with a Cosmetic Regimen Containing a Novel Cosmetic Peptide, Acetyl Dipeptide-31 Amide
J Drugs Dermatol 2025 May 1;24(5):51181s-14 PMID 40327583

Juventix Solutions for Pre-Aging Skin Treatment

Juventix Regenerative Medical offers the most current treatments, devices and biologics to treat and combat aging of the skin. Juventix Regenerative Medical has topicals such as peptides, exosomes and Privive Serum, which is an advanced skin permeation system.

Juventix Regenerative Medical provides devices such as the Radiance RF and NanoPen for micro needling. The DermaMend Laser for the specific use of therapeutic wavelengths of light is available for various skin applications.

Juventix Regenerative Medical now offers the Apollo Duet which applies electroporation and iontophoresis to drive various serums and platelet rich plasma into the deep tissues without the piercing of the skin.

Juventix Regenerative Medical is a leader in regenerative medical products. From Platelet Rich Plasma to the Apollo Duet, with customer support and professional consultant assistance not seen with other competitors, Juventix is the leader in the regenerative medical field.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Dr. Robert McGrath

The post Pre-Aging Skin: Causes, Signs, and Treatments appeared first on Juventix.

Softball has become a popular sport for young and old alike. There are leagues for collage, professionals, women, men, golden age participants and Olympic athletes. In the United States alone there are 245,000 teams playing all levels of softball.

It is interesting to note how the game was invented. The earliest known softball game was played in Chicago on Thanksgiving Day in 1887. It took place when a gathering of men waited to hear the results of the Harvard Yale football game. When the score was announced and all bets were paid, a Yale alumnus threw a boxing glove at a Harvard supporter. The Harvard grad grabbed a stick and hit the rolled-up glove and another man yelled, “Play Ball”. The game of softball began, and the boxing glove was tightened into a ball and a broom handle served as a bat. Since the ball was soft, softball was invented.

Softball Participation and Injury Trends in the United States

Since the invention, softball has become one of the most popular sports in the US. Some estimates are that 40 million Americans will play at least one softball game a year. With young and old participating in this sport, injuries are a common occurrence.

Senior softball is thriving in the United States with more than 1.5 million active players aged 50 and above participating in leagues nationwide. Senior Softball USA reports teams in all 50 states and parts of Canada, with divisions for players in their 50s, 60s, 70s, and even 80 and above. The surge in participation highlights the importance of injury prevention and strategies tailored to older athletes.

The Silver Senior Softball League of South Jersey was contacted and asked about the most common injuries incurred during participation. They noted five common injuries.

• Hamstring injuries
• Sprains and strains
• Tendinitis
• Shoulder and rotator cuff injuries
• Fractures

Risk Factors for Hamstring Injury

• Age- Senior players are at high risk due to reduced muscle elasticity and strength.
• Previous Injury- Hamstring injuries have a high rate of reoccurrence.
• Fatigue- sore overstressed muscles are prone to injury.
• Poor biomechanics- improper running technique or posture
• Obesity-Hamstrings can be overloaded with excess weight bearing.

Anatomy of the Hamstring

The hamstring muscle group consists of three muscles located at the posterior thigh. These are the semitendinosus, semimembranosus and the biceps femoris. These muscles originate from the ischial tuberosity and insert below the knee joint. Their primary function includes hip extension and knee flexion. The biceps femoris has a long and short head, with the long head being biarticular. This muscle is the commonly injured in hamstring injuries due to the complex role during sprinting.

Prevention Strategies

• Proper Warm Up with dynamic stretches and progressive movement drills.
• Strength training with focus on hamstrings, core and glutes
• Flexibility to maintain normal ranges of motion.
• Overall conditioning and agility drill specific to the activity
• Biomechanics analysis to evaluate and identify movement flaws.

Standard Treatment Options

Standard treatment of hamstring injuries includes the RICE protocol (rest, ice, compression and elevation), non-steroidal anti-inflammatory agents and rehabilitation. Physical therapy with neuromuscular training and stretching are an integral part of the recovery protocol.

In complete tears, surgical repair may be needed but surgery may prolong recovery times and lead to common surgical complications.

Recovery Timeline by Grade

• Grade 1- mild strain- typically 1-2 weeks, minimal pain and no significant lost strength.
• Grade 2- partial tear- 4-8 weeks, noticeable pain, swelling and weakness.
• Grade 3- complete tear- 3-6 months or more, severe pain, bruising and loss of function.

Diagnosis is typically clinical with confirmation by ultrasound or MRI.

Re-injury is common with approximately 30% recurrence rates in highly trained athletes in the same season. Older individual’s reoccurrence rates are higher.

In professional soccer, in the most elite leagues, each hamstring injury cost the club approximately $30-$50 thousand dollars in lost wages and associated costs. In the NFL, hamstring injuries are among the top causes of missed playing time. In high caliber players, each lost game can contribute to millions of dollars in lost player availability annually.

Platelet Rich Plasma (PRP) for Hamstring Injury Treatment

Platelet Rich Plasma is an autologous blood derived concentrate, rich in growth factors, cytokines and bioactive proteins. In thousands of published peer reviewed and double blind studies, platelet rich plasma has been proven to regenerate damaged tissues.

Platelet Rich Plasma contains growth factors that stimulate muscle repair and rejuvenation in injuries such as hamstring tears and ligamentous injuries.

• Insulin like Growth Factor – stimulates muscle cell proliferation, differentiation and repair. It has a variant called IGF-1Ea and IGF-1Ec called Mechano Growth Factor which localizes to muscle and is highly anabolic after injury.
• Fibroblast Growth Factor – supports cell proliferation and angiogenesis during muscle healing.
• Hepatocyte Growth Factor – activates quiescent satellite cells which are often released after acute injury.
• Vascular Endothelial Growth Factor – promotes blood vessel growth supporting oxygen and nutrient delivery to regenerating muscle.
• Transforming Growth Factor Beta – stimulates collagen synthesis and promotes extracellular matrix remodeling.
• Platelet Derived Growth Factor – stimulates fibroblast proliferation and collagen production in tendon and ligament repair.
• Fibroblast Growth Factor – involved in tendon repair promoting fibroblast proliferation and new collagen formation.

There have been at least 300 growth factors identified and carried on the granules of the platelets. These are released into areas of tissue damage and activate the overall bodies repair cascade. Studies have proven a 26% reduction in return to play time for hamstring injures when platelet rich plasma is used in the treatment.

Clinical Studies Supporting PRP

Update on the Use of Platelet Rich Plasma Injections in the Management of Musculoskeletal Injuries: A Systematic Review of Studies From 2014 to 2021
Orthop J Sports Med 2022 Dec 9;10(12): 23259671221140888 PMID 36532150
Purpose: To determine if there are any recent studies that show any clear benefits regarding the use of PRP in the management of soft tissue injuries
Conclusion: Six studies examined PRP in acute soft tissue injuries with two of these reporting significant improvements in recovery time for hamstring injuries.

Hamstring Injuries: A Current Concepts Review: Evaluation, Nonoperative Treatment, and Surgical Decision Making
Am J Sports Med 2024 Mar;52(3):832-844 PMID 37092718
Conclusion: Many hamstring injuries can be successfully managed with nonoperative measures such as activity modification and physical therapy and adjuncts such as platelet rich plasma injections.

Platelet Rich Plasma Injection for the Treatment of Hamstring Injuries: A Systematic Review and Meta-analysis with Best-Worst Case Analysis
Am J Sports Med 2021 Feb;49(2):529-537 PMID 32427520
Conclusion: There has been statistically nonsignificant evidence to suggest that PRP injection and physical therapy reduced return to play or reinjury rates compared to no treatment or physical therapy alone for hamstring injuries in a short term follow up.

Authors note: In review of this study, there was improvement in all areas reviewed. Although this author concluded it was not significant statistically.

Hamstring Injury Treatments and Management in Athletes: A Systematic Review of the Current Literature
JBJS Rev 2023 Nov 20;11(11). Doi: 10.2106/JBJS.RVW.23.00161 PMID 37983561
Conclusion: Treatments for hamstring injuries exhibit varied efficacy. Although rest, ice, compression and elevation remain essential for acute management, rehabilitation focusing on muscle strengthening and flexibility is critical. The potential benefits of platelet rich plasma injections, especially in chronic cases, requires more research.

Authors note: Research and studies all show benefit of platelet rich plasma for hamstring injuries. However, in some studies the benefit was not deemed to be significant. There were no noted side effects from the platelet rich plasma and in most cases, the amount of PRP, the number of injections, the activation method and the mode of image guidance was not mentioned. With the amount of growth factors, cytokines and bioactive protein that are contained in platelet rich plasma, no allergic manifestations and a favorable side effect profile, consideration should be given for platelet rich plasma to be a cornerstone in the treatment protocol for these injuries.

Juventix Regenerative Solutions for PRP and Soft Tissue Recovery

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are designed for safety, sterility and effectiveness. Our kits are FDA cleared and scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

Juventix Regenerative Medical offers a patented LED Activator to activate the platelets and begin the regenerative process. The activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA.

Juventix Regenerative Medical is proud to be a distributor of the PhysioPRO Shockwave System. This clinical grade radial shock wave device induces intracellular and extracellular reactions to assist in the repair and regeneration of tissues. The wave activates cellular pathways that drive the healing process. Shock wave treatment stimulates angiogenesis and neogenesis. These metabolic processes form new blood vessels to better oxygenate damaged tissues and mediates repair. The shock wave also modulates and overloads pain receptors to decrease pain. Treatments with the PhysioPRO can attract mesenchymal stem cells to migrate to the damaged tissue area for enhanced cellular regeneration. The PhysioPRO complements Platelet Rich Plasma and they both work synergistically in repair and regeneration. This dual approach would be advantageous in the treatment of hamstring injuries.

Juventix Regenerative Medical has a vast array of products, devices and services tailored for the medical and regenerative professional. Platelet Rich Plasma Kits and the PhysioPRO are two of the many devices that offer the latest in the treatment of soft tissue, ligamentous and hamstring injuries.

With our premier line of products and support from our experienced staff, Juventix Regenerative Medical is poised to aid any professional in enhancing clinical outcomes while increasing patient satisfaction.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,
Dr. Robert McGrath

The post Hamstring Injuries and Platelet Rich Plasma: A Regenerative Approach appeared first on Juventix.